Literature DB >> 27502500

Epidemiological study of adult-onset Still's disease using a Japanese administrative database.

Nobuo Sakata1, Sayuri Shimizu1, Fumio Hirano2, Kiyohide Fushimi3.   

Abstract

Adult-onset Still's disease (AOSD) is a rare disease, and large epidemiological studies of this disease are limited. Furthermore, it has been difficult to show the incidence and characteristics of severe AOSD complications due to the rarity of this disease. The aim of our study was to describe the demographics of AOSD and the incidence and characteristics of severe complications. Using a large Japanese administrative database, we identified hospitalized patients with AOSD and described the demographics. We also calculated the incidence of severe complications (i.e., macrophage activation syndrome [MAS] and disseminated intravascular coagulation [DIC]) and in-hospital mortality in AOSD patients, and then analyzed the age-controlled difference between men and women. We identified 513 patients with AOSD (mean age: 53.1 years; women 64.1 %). According to the age distribution, there was no distinct peak age. The thirties and the sixties were relatively large age groups. There were 76 patients of AOSD with MAS or DIC observed in this study. The incidence of severe complications was 14.8 %, 95 % CI [11.9, 18.2]. Women were more likely to have severe complications than men after controlling for age (odds ratio: 2.07; [1.14, 3.73]; p = 0.014). AOSD does not predominantly affect young adults in our study population. Elderly AOSD patients can be observed more than before due to global population aging. Severe complications are more likely to occur in women than in men.

Entities:  

Keywords:  Adult-onset Still’s disease; Epidemiology; Macrophage activation syndrome; Population aging

Mesh:

Year:  2016        PMID: 27502500     DOI: 10.1007/s00296-016-3546-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases.

Authors:  Xiao-Dan Kong; Dong Xu; Wen Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2010-06-14       Impact factor: 2.980

2.  Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.

Authors:  Aleksander Lenert; Qingping Yao
Journal:  Semin Arthritis Rheum       Date:  2015-11-10       Impact factor: 5.532

3.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

4.  Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients.

Authors:  Arnaud Hot; Myew-Ling Toh; Brigitte Coppéré; Laurent Perard; Marie Hélène Girard Madoux; Christelle Mausservey; Hélène Desmurs-Clavel; Martine Ffrench; Jacques Ninet
Journal:  Medicine (Baltimore)       Date:  2010-01       Impact factor: 1.889

Review 5.  Diagnosis and classification of adult Still's disease.

Authors:  Naim Mahroum; Hussein Mahagna; Howard Amital
Journal:  J Autoimmun       Date:  2014-01-31       Impact factor: 7.094

6.  Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases.

Authors:  J M Wouters; L B van de Putte
Journal:  Q J Med       Date:  1986-11

7.  Stroke care units versus general medical wards for acute management of stroke in Japan.

Authors:  Takahiro Inoue; Kiyohide Fushimi
Journal:  Stroke       Date:  2013-08-29       Impact factor: 7.914

8.  Epidemiology and outcome of adult-onset Still's disease in Northern Norway.

Authors:  K J Evensen; H C Nossent
Journal:  Scand J Rheumatol       Date:  2006 Jan-Feb       Impact factor: 3.641

9.  Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients.

Authors:  Mathieu Gerfaud-Valentin; Delphine Maucort-Boulch; Arnaud Hot; Jean Iwaz; Jacques Ninet; Isabelle Durieu; Christiane Broussolle; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2014-03       Impact factor: 1.889

Review 10.  Life-threatening complications of adult-onset Still's disease.

Authors:  Petros Efthimiou; Sabeeda Kadavath; Bella Mehta
Journal:  Clin Rheumatol       Date:  2014-01-17       Impact factor: 2.980

View more
  9 in total

1.  Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims database.

Authors:  Aleksander Lenert; GYeon Oh; Michael J Ombrello; Sujin Kim
Journal:  Rheumatology (Oxford)       Date:  2020-07-01       Impact factor: 7.580

2.  Clinical characteristics and treatment of elderly onset adult-onset Still's disease.

Authors:  Dai Kishida; Takanori Ichikawa; Ryota Takamatsu; Shun Nomura; Masayuki Matsuda; Wataru Ishii; Tatsuo Nagai; Sadahiro Suzuki; Ken-Ichi Ueno; Naoki Tachibana; Yasuhiro Shimojima; Yoshiki Sekijima
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

3.  Pulmonary arterial hypertension and acute respiratory distress syndrome in a patient with adult-onset stills disease.

Authors:  Grant H Lowther; Jason Chertoff; Jessica Cope; Hassan Alnuaimat; Ali Ataya
Journal:  Pulm Circ       Date:  2017-06-06       Impact factor: 3.017

Review 4.  Mechanisms, biomarkers and targets for adult-onset Still's disease.

Authors:  Eugen Feist; Stéphane Mitrovic; Bruno Fautrel
Journal:  Nat Rev Rheumatol       Date:  2018-10       Impact factor: 20.543

5.  Latent class analysis of 216 patients with adult-onset Still's disease.

Authors:  Takahiro Sugiyama; Shunsuke Furuta; Masaki Hiraguri; Kei Ikeda; Yosuke Inaba; Shin-Ichiro Kagami; Yasuhiko Kita; Kei Kobayashi; Yoshihisa Kobayashi; Kazuhiro Kurasawa; Daiki Nakagomi; Yasushi Nawata; Yohei Kawasaki; Yuki Shiko; Takao Sugiyama; Hiroshi Nakajima
Journal:  Arthritis Res Ther       Date:  2022-01-03       Impact factor: 5.156

6.  Detection and Prediction of Macrophage Activation Syndrome in Still's Disease.

Authors:  Clément Javaux; Thomas El-Jammal; Pierre-Antoine Neau; Nicolas Fournier; Mathieu Gerfaud-Valentin; Laurent Perard; Marine Fouillet-Desjonqueres; Julie Le Scanff; Emmanuelle Vignot; Stéphane Durupt; Arnaud Hot; Alexandre Belot; Isabelle Durieu; Thomas Henry; Pascal Sève; Yvan Jamilloux
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

7.  Bibliometrics analysis on the research status and trends of adult-onset Still's disease: 1921-2021.

Authors:  Aining Qin; Jing Sun; Chao Gao; Chunying Li
Journal:  Front Immunol       Date:  2022-07-18       Impact factor: 8.786

Review 8.  Adult-onset Still's disease: A disease at the crossroad of innate immunity and autoimmunity.

Authors:  Shijia Rao; Lemuel Shui-Lun Tsang; Ming Zhao; Wei Shi; Qianjin Lu
Journal:  Front Med (Lausanne)       Date:  2022-08-22

9.  Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Authors:  Jurgen Sota; Donato Rigante; Piero Ruscitti; Antonella Insalaco; Paolo Sfriso; Salvatore de Vita; Rolando Cimaz; Giuseppe Lopalco; Giacomo Emmi; Francesco La Torre; Claudia Fabiani; Alma Nunzia Olivieri; Marco Cattalini; Daniele Cammelli; Romina Gallizzi; Maria Alessio; Raffaele Manna; Ombretta Viapiana; Micol Frassi; Manuela Pardeo; Armin Maier; Carlo Salvarani; Rosaria Talarico; Marta Mosca; Serena Colafrancesco; Roberta Priori; Maria Cristina Maggio; Carla Gaggiano; Salvatore Grosso; Fabrizio De Benedetti; Antonio Vitale; Roberto Giacomelli; Luca Cantarini
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.